LAB International Announces Positive Fentanyl Phase IIA Results
Sat, 15 Jul 2006 06:00 AM EST
... LAB International Inc. (TSX:LAB, Frankfurt: LD9.F, XETRA: LD9.DE) ("LAB"), an integrated drugdevelopment company with subsidiaries focused on developing therapies forthe inhalation market and on providing contract research services, todayannounced positive results for the first phase II trial of its leadproduct, Fentanyl TAIFUN(R), in breakthrough cancer pain. [click link for full article] ...
Related Topics
- International Health
- Fentanyl Skin Patches
- Fentanyl lozenges
- D-dimer
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Tb
- BNP
- Fentanyl
- Urinalysis
- Chemical Safety
- Cytology
- Trypsin
- Fentanyl Transmucosal Lozenge
- Brain injury that results in physical, emotional, or intellectual changes or deficits
- Peritoneal Dialysis
- Typhoid Fever
- Fentanyl Citrate Injection
- International Classification of Diseases
- Diagnostic Tests

Not Signed In -

